1. The de novo missense mutation F224S in GABRB2, identified in epileptic encephalopathy and developmental delay, impairs GABA A R function.
- Author
-
Li PP, Zhou YY, Gao L, Lv JN, Xu SS, Zhao YW, Xu D, Huang R, Zhang X, Li P, Fu X, and He Z
- Subjects
- Humans, HEK293 Cells, Male, Female, Receptors, GABA-A genetics, Mutation, Missense, Developmental Disabilities genetics, Developmental Disabilities physiopathology, Epilepsy genetics, Epilepsy physiopathology
- Abstract
Genetic variants in genes encoding subunits of the γ-aminobutyric acid-A receptor (GABA
A R) have been found to cause neurodevelopmental disorders and epileptic encephalopathy. In a patient with epilepsy and developmental delay, a de novo heterozygous missense mutation c.671 T > C (p.F224S) was discovered in the GABRB2 gene, which encodes the β2 subunit of GABAA R. Based on previous studies on GABRB2 variants, this new GABRB2 variant (F224S) would be pathogenic. To confirm and investigate the effects of this GABRB2 mutation on GABAA R channel function, we conducted transient expression experiments using GABAA R subunits in HEK293T cells. The GABAA Rs containing mutant β2 (F224S) subunit showed poor trafficking to the cell membrane, while the expression and distribution of the normal α1 and γ2 subunits were unaffected. Furthermore, the peak current amplitude of the GABAA R containing the β2 (F224S) subunit was significantly smaller compared to the wild type GABAA R. We propose that GABRB2 variant F224S is pathogenic and GABAA Rs containing this β2 mutant reduce response to GABA under physiological conditions, which could potentially disrupt the excitation/inhibition balance in the brain, leading to epilepsy., (Copyright © 2024 IBRO. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF